Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Model Medicines logo — Precision Medicines, Broad Applications

Model Medicines

Precision Medicines, Broad Applications

Founded 2019 United States La Jolla, United States 15 employees Seed Total: $4.10M AI, Biotechnology +2

General Information

Company Name Model Medicines
Founded Year 2019
Location United States La Jolla, United States
Employees 15
Industries AI, Biotechnology, Pharmaceutical +1
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Model Medicines. To contact Model Medicines, visit modelmedicines.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Model Medicines compare?

A PDF of Model Medicines and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Model Medicines soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Model Medicines

Model Medicines, founded in 2019, is an AI-driven, human health company dedicated to utilizing AI to model all of chemistry and human biology in order to expedite the development of life-changing drugs. With a focus on AI-drug discovery, the company has already amassed an impressive portfolio of 182 compounds for 26 targets. Their robust pipeline includes patent-pending therapeutics for a wide array of health concerns such as oncology, infectious diseases, gastric disorders, neurological disorders, and weight disorders. Based in La Jolla, CA, the company recently secured a notable $4.10M Seed Round investment on 01 February 2021, with participation from influential investors including Nex Cubed, 8VC, Irving Investors, Triton Funds, Particle Accelerator Limited (ParticleX), Carter Comstock, and Friedman BioVentures. Model Medicines' pioneering approach positions it at the forefront of the biotechnology and pharmaceutical industries, offering promising prospects for innovative drug development propelled by AI technology. This startup holds substantial potential for groundbreaking contributions to the healthcare landscape.

Business keywords: AI-driven healthcare, Drug discovery, Chemistry modeling, Biology modeling, Therapeutics development, Oncology drugs, Infectious disease drugs, Gastric disorder drugs, Neurological disorder drugs, Weight disorder drugs, Patent-pending drugs, Life sciences, La Jolla, CA, Health technology

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $4.10M 7
Nex Cubed 8VC Irving Investors
Nex Cubed, 8VC +5
01 Feb 2021

Model Medicines Alternatives & Competitors

View All Alternatives
Model Medicines vs
Drug Discovery & Development
Drug Discovery & Development United States

Strategies and technologies driving drug discovery to market.

10 employees
Biotechnology, Pharmaceutical
Model Medicines vs
Ventus Therapeutics
Ventus Therapeutics United States

Pioneering a unique approach to structure-based drug discovery. Located in Waltham, MA and Montreal,...

Grant
55 employees
Biotechnology, Health Care
Model Medicines vs
1910 Genetics
1910 Genetics United States

Advancing small and large molecule drug discovery with a multimodal AI platform powered by laborator...

Venture round
37 employees
AI, Biotechnology
View all alternatives

FAQ About Model Medicines

Precision Medicines, Broad Applications
Model Medicines was founded in 2019.
Model Medicines is headquartered in La Jolla, United States.
Model Medicines operates in AI, Biotechnology, Pharmaceutical and Machine Learning. Its work centres on AI-driven healthcare, Drug discovery, Chemistry modeling and Biology modeling.
Model Medicines has approximately 15 employees.
Model Medicines has completed 1 funding round, raising a total of $4.10M. The latest funding stage is Seed.
Top alternatives and competitors to Model Medicines include Drug Discovery & Development, Ventus Therapeutics, 1910 Genetics, Lodo Therapeutics Corporation, Eli Lilly and Company. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Model Medicines and Drug Discovery & Development are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Model Medicines, https://bouncewatch.com/company/model-medicines, updated 28 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes